At ALKemist Bio we are developing TCR-T cells that possess the ability to specifically target ALK antigens found on ALK-positive cancer cells, primarily focusing on non-small cell lung cancer patients. By harnessing the power of the immune system and engineering T cells to precisely recognize and combat these cancerous cells, we aim to pave the way for more effective treatments aiming at improving the standard of care.
Company Details
- Employees
- 5
- Founded
- 2023
- Address
- Via Ettore De Sonnaz, 19, Turin,piedmont 10121,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.alkemistbio.com/
- HQ
- Turin, Piedmont
Alkemist Bio Questions
Alkemist Bio's website is https://www.alkemistbio.com/
Alkemist Bio's LinkedIn profile is https://it.linkedin.com/company/alkemist-bio
Alkemist Bio has
5 employees.
View email and phone details for 5
employees at Alkemist Bio.
Alkemist Bio's industry is
Biotechnology Research
Alkemist Bio's top competitors are
Aeva Biotech,
Addaxbiosciences,
Agomab,
Italy In Biotech,
Resalis Therapeutics,
Claris Ventures,
Kither Biotech,
Heqet Therapeutics,
Neophore Ltd,
Agora Labs.
Alkemist Bio's categories are Biotechnology Research
Alkemist Bio's founding year is 2023
